This document reviews polymorphism in pharmaceutical compounds. It discusses how polymorphism can impact properties like solubility, dissolution rate, stability and bioavailability. Several techniques for characterizing polymorphs are described, including X-ray powder diffraction, differential scanning calorimetry, and infrared spectroscopy. The key types of polymorphism - enantiotropy, monotropy, and dynamic allotropy - are explained. The importance of evaluating and controlling polymorphism in drug development and manufacturing is emphasized.